Soberana Plus
Soberana Plus
Soberana Plus (pronunciation: so-be-ra-na pluhs) is a COVID-19 vaccine developed by the Finlay Institute in Cuba. It is part of the Soberana family of vaccines, which also includes Soberana 01 and Soberana 02.
Etymology
The term "Soberana" is derived from the Spanish word for "sovereign," reflecting Cuba's aim to achieve health sovereignty by developing its own vaccines. The "Plus" signifies an additional or enhanced version of the original Soberana vaccine.
Description
Soberana Plus is a protein subunit vaccine, which means it uses a harmless piece of the virus to trigger an immune response. It is designed to be used as a booster shot following a two-dose regimen of Soberana 02.
Efficacy
According to the Finlay Institute, when Soberana Plus is used as a booster following Soberana 02, the combination has shown an efficacy rate of over 90% in preventing symptomatic COVID-19.
Related Terms
External links
- Medical encyclopedia article on Soberana Plus
- Wikipedia's article - Soberana Plus
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski